There are numerous positions posted for Sales Rep and a DM... Any insight? Is this for an expansion or did the entire district jump ship?
The company has been removing WH reps for years now. It's a dying portfolio, with only LoLo as a bright spot. Don't waste your time bud.
they have jumped ship to a different position within company. Same is happening for many others leaving Women Health. Abbvie having a large Women Health salesforce with an underperforming low revenue product is pretty much causing the exodus. It’s good if you are just trying to get by and get some experience...
In light of the recently released Global Position Statement by 11 societies in the use of tetsosterone in treating HSDD, will the combined company dust off Intrinsa and/or aquire the Libigel safety data (largest testosterone safety trial with 3656 patients) led by AbbVie's Dr Michael Snabes when he was with Biosante. According to Snabes during the unblinded examinations with 4000 patient years which was over half way through the pre-marketing safety data required by the FDA , they found that restoring T -levels to premenopausal levels reduced cardiovascular events by 70% in menopausal women at risk of experiencing cardiovascular events. It also appears to have reduced breats cancer events by an undisclosed amount. Simply switching compounded and off label Testoterone presently be prescribed to an FDA approved drug should generate over 4 million prescriptions. Note: The position statement did not have the benefit of reviewing the Libigel Safety data. https://www.menopause.org.au/images/docs/ICMT_A_1637079_O.pdf
